Japan Urged to Reject Proposal for Annual Cuts to Drug Prices

International Pharmaceutical Regulatory Monitor
A A
The U.S. government and life sciences industry groups have asked Japan not to change the country’s drug pricing system to annual price reviews and cuts, instead of the current two-year review.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor